Literature DB >> 21655931

A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world.

William D Leslie1, John T Schousboe.   

Abstract

Fracture rates are known to vary by more than an order of magnitude worldwide; therefore, a single approach cannot be universally applied to all countries. National considerations must reflect the burden of osteoporosis, available resources, the disease costs to the individual and society, and how these relate to competing health and other societal priorities. Recent developments in terms of diagnosis, fracture risk prediction, and therapeutic options have prompted many countries to review and update their clinical practice guidelines (CPGs) for the prevention and management of osteoporosis intended for use in primary care in the general adult population. This paper reviews recently updated CPGs from the following countries: Australia, Belgium, Canada, Germany, the United Kingdom, and the United States.

Entities:  

Mesh:

Year:  2011        PMID: 21655931     DOI: 10.1007/s11914-011-0060-5

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  40 in total

1.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Authors:  Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie
Journal:  CMAJ       Date:  2010-10-12       Impact factor: 8.262

2.  The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada.

Authors:  J D Adachi; G Loannidis; C Berger; L Joseph; A Papaioannou; L Pickard; E A Papadimitropoulos; W Hopman; S Poliquin; J C Prior; D A Hanley; W P Olszynski; T Anastassiades; J P Brown; T Murray; S A Jackson; A Tenenhouse
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

3.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

4.  Mortality after all major types of osteoporotic fracture in men and women: an observational study.

Authors:  J R Center; T V Nguyen; D Schneider; P N Sambrook; J A Eisman
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

5.  Mortality after osteoporotic fractures.

Authors:  O Johnell; J A Kanis; A Odén; I Sernbo; I Redlund-Johnell; C Petterson; C De Laet; B Jönsson
Journal:  Osteoporos Int       Date:  2003-10-30       Impact factor: 4.507

6.  Excess mortality after hospitalisation for vertebral fracture.

Authors:  John A Kanis; Anders Oden; Olof Johnell; Chris De Laet; Bengt Jonsson
Journal:  Osteoporos Int       Date:  2003-11-04       Impact factor: 4.507

7.  FRAX assessment of osteoporotic fracture probability in Switzerland.

Authors:  K Lippuner; H Johansson; J A Kanis; R Rizzoli
Journal:  Osteoporos Int       Date:  2009-06-11       Impact factor: 4.507

8.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

9.  International variations in hip fracture probabilities: implications for risk assessment.

Authors:  John A Kanis; Olof Johnell; Chris De Laet; Bengt Jonsson; Anders Oden; Alan K Ogelsby
Journal:  J Bone Miner Res       Date:  2002-07       Impact factor: 6.741

10.  The components of excess mortality after hip fracture.

Authors:  J A Kanis; A Oden; O Johnell; C De Laet; B Jonsson; A K Oglesby
Journal:  Bone       Date:  2003-05       Impact factor: 4.398

View more
  20 in total

Review 1.  Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density.

Authors:  S Nayak; D L Edwards; A A Saleh; S L Greenspan
Journal:  Osteoporos Int       Date:  2015-02-03       Impact factor: 4.507

2.  Use of a performance algorithm improves utilization of vertebral fracture assessment in clinical practice.

Authors:  J T Schousboe; F McKiernan; J T Fuehrer; N Binkley
Journal:  Osteoporos Int       Date:  2014-03       Impact factor: 4.507

Review 3.  Comparison between various fracture risk assessment tools.

Authors:  W D Leslie; L M Lix
Journal:  Osteoporos Int       Date:  2014-01       Impact factor: 4.507

4.  Bone: New guidelines for multistep fracture prevention in men.

Authors:  Piet P M Geusens; Joop P van den Bergh
Journal:  Nat Rev Rheumatol       Date:  2012-09-18       Impact factor: 20.543

Review 5.  Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review.

Authors:  S Nayak; D L Edwards; A A Saleh; S L Greenspan
Journal:  Osteoporos Int       Date:  2013-10-09       Impact factor: 4.507

Review 6.  Cancer-associated bone disease.

Authors:  R Rizzoli; J-J Body; M-L Brandi; J Cannata-Andia; D Chappard; A El Maghraoui; C C Glüer; D Kendler; N Napoli; A Papaioannou; D D Pierroz; M Rahme; C H Van Poznak; T J de Villiers; G El Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2013-10-22       Impact factor: 4.507

7.  DEVELOPMENT OF CLINICAL RISK ASSESSMENT TOOL FOR OSTEOPOROSIS (OSTEORISKAPP) USING A SYNDROMIC APPROACH.

Authors:  O Yilmaz; V Mevsim; E Kuruoglu
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

Review 8.  The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.

Authors:  Elizabeth M Curtis; Rebecca J Moon; Nicholas C Harvey; Cyrus Cooper
Journal:  Bone       Date:  2017-01-22       Impact factor: 4.398

9.  Reprint of: The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.

Authors:  Elizabeth M Curtis; Rebecca J Moon; Nicholas C Harvey; Cyrus Cooper
Journal:  Int J Orthop Trauma Nurs       Date:  2017-04-26

10.  In Vivo Study on the Pharmacological Interactions between a Chinese Herbal Formula ELP and Antiresorptive Drugs to Counteract Osteoporosis.

Authors:  Chun-Hay Ko; Wing-Sum Siu; Hing-Lok Wong; Si Gao; Wai-Ting Shum; Ching-Po Lau; Sau-Wan Cheng; Jacqueline Chor-Wing Tam; Leung-Kim Hung; Kwok-Pui Fung; Clara Bik-San Lau; Quan-Bin Han; Ping-Chung Leung
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.